SCHEMBL61913

SCHEMBL61913

Cc1cccc(C)c1B(O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
CYP2A6 P11509 2/20 0.45
CYP1A2 P05177 1/20 0.45
ACHE P22303 2/20 0.44
TSHR P16473 2/20 0.44
TRPA1 O75762 2/20 0.43
ATM Q13315 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
CD44 P16070 1/20 0.38
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
ENPP2 Q13822 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20694978 0.97 ALDH1A1 (0.48) ALDH1A1CYP2A6CYP1A2ACHETSHR
SCHEMBL28221318 0.97 ALDH1A1 (0.48) ALDH1A1CYP2A6CYP1A2ACHETSHR
SCHEMBL31155098 0.89 ALDH1A1 (0.42) ALDH1A1CYP2A6CYP1A2ACHETSHR
Magnesium Chloride Anhydrous SCHEMBL20694943 0.89 ALDH1A1 (0.42) ALDH1A1CYP2A6CYP1A2ACHETSHR
SCHEMBL29955803 0.87 TRPA1 (0.52) ALDH1A1CYP2A6CYP1A2ACHETSHR
SCHEMBL15475941 0.87 TRPA1 (0.52) ALDH1A1CYP2A6CYP1A2ACHETSHR
SCHEMBL29957352 0.85 ALDH1A1 (0.39) ALDH1A1CYP2A6CYP1A2ACHETSHR
SCHEMBL29427089 0.85 ACHE (0.48) ALDH1A1CYP2A6CYP1A2ACHETSHR
SCHEMBL6007162 0.85 ACHE (0.48) ALDH1A1CYP2A6CYP1A2ACHETSHR
SCHEMBL3782806 0.85 CD44 (0.50) ALDH1A1CYP2A6CYP1A2ACHETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1772 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
US-20240254150-A1 CONFORMATIONALLY RESTRICTED SULFONATE BASED PHOSPHINE LIGANDS FOR HINDERED SUZUKI COUPLING REACTIONS TCG GreenChem Inc. (US) 2024-08-01 US claimed
CN-117776149-A Boron-sodium doped hard carbon composite material, preparation method thereof and sodium ion battery 四川星耀新能源科技有限公司 2024-03-29 CN claimed
CN-113444125-B Phosphoramidite ligand, preparation method thereof and application thereof in asymmetric carbonylation reaction 西北大学 2024-01-26 CN claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11793220-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-10-24 US claimed
CN-116916755-A Materials and methods for extending the shelf life of food products JP实验室公司 2023-10-20 CN claimed
CN-103613823-B A kind of anticorrosive wood-plastic composite sectional material ANHUI HUANJIA TIANYI REGENERATION RESOURCE CO.,LTD. (CN) 2016-03-02 CN claimed
CN-103613823-A Corrosion resistant wood and plastic composite material ANHUI HUANJIA TIANYI RENEWABLE RESOURCES CO LTD 2014-03-05 CN claimed
CN-102731370-B Preparation method of ionic liquid and synthesizing method of biphenyl compounds by applying palladium carbon catalysis in ionic liquid UNIV HEILONGJIANG 2013-10-16 CN claimed
EP-1506176-B1 AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PFIZER ITALIA SRL (IT) 2013-04-24 EP claimed
US-8361484-B2 Polymer systems for lung volume reduction therapy AERIS THERAPEUTICS, INC. (US) 2013-01-29 US claimed
US-20100236924-A1 LIQUID ELECTROLYTE COMPOSITION AND ITS USE IN GAS SENSORS LIFE SAFETY DISTRIBUTION AG (CH) 2010-09-23 US claimed
EP-2226627-A1 Liquid electrolyte composition and its use in gas sensors Life Safety Distribution AG (CH) 2010-09-08 EP claimed
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy CANADIAN IMPERIAL BANK OF COMMERCE (CA) 2010-02-18 US claimed
EP-2059227-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY Aeris Therapeutics, Inc. (US) 2009-05-20 EP claimed
WO-2008039827-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY AERIS THERAPEUTICS, INC. (US) 2008-04-03 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240254150-A1 CONFORMATIONALLY RESTRICTED SULFONATE BASED PHOSPHINE LIGANDS FOR HINDERED SUZUKI COUPLING REACTIONS STS, PTPRS, PFKFB1 ALDH1A1 1400/4885CYP2A6 2415/4885CYP1A2 4111/4885
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy GFER, MUC1, CTH ALDH1A1 1749/4885CYP2A6 1752/4885CYP1A2 2482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.